Biophytis S.A. (BPTSY)
USD 3.05
(0.0%)
USD 3.05
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 14.33 Million EUR | -40.76% |
| 2022 | 27.54 Million EUR | -24.44% |
| 2021 | 36.45 Million EUR | 88.05% |
| 2020 | 19.38 Million EUR | -5.2% |
| 2019 | 20.44 Million USD | 3.36% |
| 2018 | 19.78 Million USD | 43.17% |
| 2017 | 13.81 Million USD | 33.17% |
| 2016 | 10.37 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 2368.62 USD | -43.78% |
| 2024 Q2 | 2351.37 USD | 0.0% |
| 2023 Q4 | 8.43 Million USD | 204157.93% |
| 2023 FY | 16.31 Million EUR | -40.76% |
| 2023 Q1 | 3538.34 USD | -99.97% |
| 2023 Q3 | 4127.81 USD | -99.95% |
| 2023 Q2 | 7.88 Million USD | 222714.98% |
| 2022 FY | 27.54 Million EUR | -24.44% |
| 2022 Q2 | 15.71 Million USD | 0.0% |
| 2022 Q4 | 11.97 Million USD | 0.0% |
| 2021 Q2 | 15.13 Million USD | 0.0% |
| 2021 Q4 | 21.21 Million USD | 0.0% |
| 2021 FY | 36.45 Million EUR | 88.05% |
| 2020 FY | 19.38 Million EUR | -5.2% |
| 2020 Q4 | 9.34 Million USD | 0.0% |
| 2020 Q2 | 10.01 Million USD | 0.0% |
| 2019 Q4 | 7.81 Million USD | 0.0% |
| 2019 FY | 20.44 Million USD | 3.36% |
| 2018 FY | 19.78 Million USD | 43.17% |
| 2017 FY | 13.81 Million USD | 33.17% |
| 2016 FY | 10.37 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 83.484% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -191.445% |
| SQZ Biotechnologies Company | 85.61 Million USD | 83.26% |
| Evofem Biosciences, Inc. | 29.55 Million USD | 51.501% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | 61.528% |
| Mesoblast Limited | 5.9 Million USD | -142.85% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -854.325% |
| Genus plc | 147.7 Million USD | 90.296% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -63.26% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -968.395% |
| Marizyme, Inc. | 19.23 Million USD | 25.504% |
| ContraFect Corporation | 56.88 Million USD | 74.805% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -71.879% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -225.109% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -869.263% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -391.49% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -413.662% |
| MultiCell Technologies, Inc. | 567.42 USD | -2525894.854% |
| Accustem Sciences Inc. | 3.74 Million USD | -282.579% |
| RVL Pharmaceuticals plc | 85.94 Million USD | 83.323% |
| EV Biologics, Inc. | 531.96 Thousand USD | -2594.365% |
| Q BioMed Inc. | 3.43 Million USD | -317.066% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | 42.007% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -3579.223% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -445.495% |
| Biomind Labs Inc. | 994.18 Thousand USD | -1341.688% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 225.49 Million USD | 93.644% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -113.352% |
| Skye Bioscience, Inc. | 13.54 Million USD | -5.798% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -599.613% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 57432.0% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -184.27% |
| IMV Inc. | 37.7 Million USD | 61.991% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | 10.476% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -681.049% |
| GB Sciences, Inc. | 1.42 Million USD | -909.005% |
| Alpha Cognition Inc. | 9.7 Million USD | -47.678% |
| HST Global, Inc. | 140.9 Thousand USD | -10071.957% |
| CSL Limited | 3.44 Billion USD | 99.584% |
| Halberd Corporation | 74.84 Thousand USD | -19051.011% |
| Enzolytics Inc. | 2.17 Million USD | -557.626% |
| Resverlogix Corp. | 12.71 Million USD | -12.752% |
| Affymax, Inc. | 39.38 Million USD | 63.609% |
| SYBLEU INC | 160.87 Thousand USD | -8809.346% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -292.609% |
| argenx SE | 1.53 Billion USD | 99.065% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | 75.047% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -1272.893% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -807.522% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -320.942% |
| AVAX Technologies, Inc. | 7.31 Million USD | -96.067% |
| Zenith Capital Corp. | 8.94 Million USD | -60.271% |
| Genscript Biotech Corporation | 825.34 Million USD | 98.263% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -82174.267% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -483.754% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -8256.996% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 85.57% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -714.524% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 1.97 Million USD | -626.813% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -668.785% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | -31.895% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -646.158% |
| BioStem Technologies, Inc. | 22.97 Million USD | 37.614% |
| ONE Bio Corp. | 6.44 Million USD | -122.428% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -7797.622% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | -973.286% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -1174.146% |
| Agentix Corp. | 1.37 Million USD | -944.865% |
| LadRx Corporation | 3.81 Million USD | -276.017% |
| Cell Source, Inc. | 4.32 Million USD | -231.372% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -3349.753% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -1452.014% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -1452.014% |
| NovAccess Global Inc. | 2.46 Million USD | -481.045% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -495.983% |
| Itoco Inc. | 919.14 Thousand USD | -1459.387% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -238.169% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -1180.876% |
| Kadimastem Ltd | 2.41 Million USD | -494.703% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -5376.338% |
| CytoDyn Inc. | 18.05 Million USD | 20.628% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -56847.038% |
| Mobile Lads Corp. | 554.54 Thousand USD | -2484.637% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -6412.691% |
| Qrons Inc. | 643.67 Thousand USD | -2126.738% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -909.514% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 2.22 Million USD | -542.77% |
| Rebus Holdings, Inc. | 664 Thousand USD | -2058.584% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -689.123% |
| International Stem Cell Corporation | 5.27 Million USD | -171.922% |
| Bioxytran, Inc. | 3.82 Million USD | -275.195% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -27127.309% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -70356.668% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | 60.478% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -785.847% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -1847.855% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -360.72% |
| Neutra Corp. | 243.82 Thousand USD | -5778.493% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | 17.895% |
| PureTech Health plc | 144.59 Million USD | 90.088% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | 30.048% |
| IXICO plc | 4.7 Million USD | -204.504% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -62.931% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 87.827% |
| CSL Limited | 3.89 Billion USD | 99.632% |
| Cellectis S.A. | 97.32 Million USD | 85.272% |